Actively Recruiting

Phase Not Applicable
Age: 65Years +
All Genders
NCT07477002

Post-Dilatation in Balloon-Expandable TAVI Prostheses

Led by Medical University of Vienna · Updated on 2026-05-12

146

Participants Needed

1

Research Sites

330 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Asymmetrical and inadequate expansion of transcatheter heart valves (THVs) have been described as a key predictor of impaired valve hemodynamic performance predisposing patients for bioprosthetic valve dysfunction (BVD) and death. Post-dilatation using the original delivery system balloon at the identical filling volume after deployment of balloon-expandable THVs represents an invasive strategy to potentially optimize expansion and reduce asymmetry of balloon-expandable THVs. Currently, the efficacy and safety of routine post-dilatation has never been assessed in a randomized controlled fashion. The present randomized controlled DUOTAP trial aims to assess efficacy and safety of routine post-dilatation on THV expansion, hemodynamics, durability, and associated clinical outcomes in patients with severe aortic stenosis.

CONDITIONS

Official Title

Post-Dilatation in Balloon-Expandable TAVI Prostheses

Who Can Participate

Age: 65Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Severe aortic stenosis
  • Treatment planned by transfemoral TAVI as decided by a heart team
  • Anatomical suitability for balloon-expandable transcatheter heart valve
  • Age 65 years or older
  • Provided informed consent
Not Eligible

You will not qualify if you...

  • Active endocarditis or active rheumatic heart disease affecting valve leaflets
  • Bicuspid aortic valve anatomy
  • Valve-in-valve procedure
  • Severe calcification of the aortic annulus risking annular rupture
  • Significant narrowing of left main or proximal left anterior descending artery causing risk during rapid ventricular pacing

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Medical University of Vienna

Vienna, State of Vienna, Austria, 1090

Actively Recruiting

Loading map...

Research Team

C

Christian Nitsche, MD, PhD

CONTACT

P

Philipp E Bartko, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here